Cargando…
Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population
INTRODUCTION: Approximately 30% of patients with a first acute pericarditis episode experience a recurrence ≤ 18 months; ~ 15% experience multiple recurrences. This study assessed the recurrence and economic burden among patients with multiple recurrences. METHODS: Adults with idiopathic pericarditi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478772/ https://www.ncbi.nlm.nih.gov/pubmed/34417724 http://dx.doi.org/10.1007/s12325-021-01868-7 |
_version_ | 1784576130573926400 |
---|---|
author | Lin, David Laliberté, François Majeski, Christine Magestro, Matt Lejeune, Dominique Duh, Mei Sheng Lim-Watson, Michelle Paolini, John F. |
author_facet | Lin, David Laliberté, François Majeski, Christine Magestro, Matt Lejeune, Dominique Duh, Mei Sheng Lim-Watson, Michelle Paolini, John F. |
author_sort | Lin, David |
collection | PubMed |
description | INTRODUCTION: Approximately 30% of patients with a first acute pericarditis episode experience a recurrence ≤ 18 months; ~ 15% experience multiple recurrences. This study assessed the recurrence and economic burden among patients with multiple recurrences. METHODS: Adults with idiopathic pericarditis were identified in the OptumHealth Care Solutions, Inc., database (2007–2017). Recurrent pericarditis (RP) was defined as ≥ 2 episodes of care separated by > 28 days; multiple recurrences were defined as ≥ 2 recurrences. RESULTS: Among 944 patients with RP, 375 (39.7%) experienced multiple recurrences and were propensity score-matched 1:1 to 375 patients without recurrence. Among patients with multiple recurrences, median disease duration (time from first episode to end of last recurrence, confirmed by a 1.5-year recurrence-free period) was 2.84 years. The multiple recurrences cohort had higher rates of hospitalizations per-patient-per-month (PPPM) than the no recurrence cohort (rate ratio [95% confidence interval (CI)] = 2.22 [1.35–3.65]). Mean total healthcare costs were significantly higher in the multiple recurrences versus no recurrence cohort ($2728 vs. $1568 PPPM, cost ratio [95% CI] = 1.74 [1.29–2.32]), mainly driven by higher hospitalization costs in the multiple recurrences cohort (mean: $1180 vs. $420 PPPM, cost ratio [95% CI] = 2.81 [1.80–4.66]). Mean work loss costs were higher in the multiple recurrences versus no recurrence cohort ($696 vs. $169 PPPM, cost ratio [95% CI] = 4.12 [1.64–9.61]). In patients with multiple recurrences, mean cost of the first episode was $19,189; subsequent recurrences ranged from $2089 to $7366 (second recurrence = $6222). CONCLUSION: In conclusion, among patients with multiple pericarditis recurrences, disease symptoms persisted several years, and healthcare and work loss costs were further compounded in this subset of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-021-01868-7. |
format | Online Article Text |
id | pubmed-8478772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-84787722021-10-08 Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population Lin, David Laliberté, François Majeski, Christine Magestro, Matt Lejeune, Dominique Duh, Mei Sheng Lim-Watson, Michelle Paolini, John F. Adv Ther Original Research INTRODUCTION: Approximately 30% of patients with a first acute pericarditis episode experience a recurrence ≤ 18 months; ~ 15% experience multiple recurrences. This study assessed the recurrence and economic burden among patients with multiple recurrences. METHODS: Adults with idiopathic pericarditis were identified in the OptumHealth Care Solutions, Inc., database (2007–2017). Recurrent pericarditis (RP) was defined as ≥ 2 episodes of care separated by > 28 days; multiple recurrences were defined as ≥ 2 recurrences. RESULTS: Among 944 patients with RP, 375 (39.7%) experienced multiple recurrences and were propensity score-matched 1:1 to 375 patients without recurrence. Among patients with multiple recurrences, median disease duration (time from first episode to end of last recurrence, confirmed by a 1.5-year recurrence-free period) was 2.84 years. The multiple recurrences cohort had higher rates of hospitalizations per-patient-per-month (PPPM) than the no recurrence cohort (rate ratio [95% confidence interval (CI)] = 2.22 [1.35–3.65]). Mean total healthcare costs were significantly higher in the multiple recurrences versus no recurrence cohort ($2728 vs. $1568 PPPM, cost ratio [95% CI] = 1.74 [1.29–2.32]), mainly driven by higher hospitalization costs in the multiple recurrences cohort (mean: $1180 vs. $420 PPPM, cost ratio [95% CI] = 2.81 [1.80–4.66]). Mean work loss costs were higher in the multiple recurrences versus no recurrence cohort ($696 vs. $169 PPPM, cost ratio [95% CI] = 4.12 [1.64–9.61]). In patients with multiple recurrences, mean cost of the first episode was $19,189; subsequent recurrences ranged from $2089 to $7366 (second recurrence = $6222). CONCLUSION: In conclusion, among patients with multiple pericarditis recurrences, disease symptoms persisted several years, and healthcare and work loss costs were further compounded in this subset of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-021-01868-7. Springer Healthcare 2021-08-21 2021 /pmc/articles/PMC8478772/ /pubmed/34417724 http://dx.doi.org/10.1007/s12325-021-01868-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Lin, David Laliberté, François Majeski, Christine Magestro, Matt Lejeune, Dominique Duh, Mei Sheng Lim-Watson, Michelle Paolini, John F. Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population |
title | Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population |
title_full | Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population |
title_fullStr | Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population |
title_full_unstemmed | Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population |
title_short | Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population |
title_sort | disease and economic burden associated with recurrent pericarditis in a privately insured united states population |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478772/ https://www.ncbi.nlm.nih.gov/pubmed/34417724 http://dx.doi.org/10.1007/s12325-021-01868-7 |
work_keys_str_mv | AT lindavid diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation AT lalibertefrancois diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation AT majeskichristine diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation AT magestromatt diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation AT lejeunedominique diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation AT duhmeisheng diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation AT limwatsonmichelle diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation AT paolinijohnf diseaseandeconomicburdenassociatedwithrecurrentpericarditisinaprivatelyinsuredunitedstatespopulation |